Pledge Therapeutics

Pledge Therapeutics

Foundation date

14/05/2019

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Small molecules

Therapeutic areas

• #Diseases of the blood and blood-forming organs - immune disorders

Pledge Therapeutics discovers and develops small molecule drugs that demonstrate target engagement and therefore deliver durable disease-modifying effect. Our goal is to bring drug candidates with novel mechanisms of action to a stage more suitable for strategic co-development.